Clinical trial
Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis
NCT02643823 is registered in ClinicalTrials.gov with Shenzhen Hornetcorn Bio-technology Company, LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis
- Lead sponsor
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- June 30, 2017
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis